192 related articles for article (PubMed ID: 12493542)
61. Tc-99m MAG3 as an alternative to Tc-99m DTPA and I-131 Hippuran for renal transplant evaluation.
O'Malley JP; Ziessman HA; Chantarapitak N
Clin Nucl Med; 1993 Jan; 18(1):22-9. PubMed ID: 8422715
[TBL] [Abstract][Full Text] [Related]
62. Will 99mTc-MAG3 replace 131I-OIH and 99mTc-DTPA in the follow-up of renal transplants?
Dubovsky EV; Russell CD; Yester MV; Thorstad BL; Ryan JP
Contrib Nephrol; 1990; 79():118-22. PubMed ID: 2146081
[No Abstract] [Full Text] [Related]
63. 99mTc-MAG3 versus 131I-orthoiodohippurate in the routine determination of effective renal plasma flow.
Bagni B; Portaluppi F; Montanari L; Prandini N; Zatta G
J Nucl Med Allied Sci; 1990; 34(2):67-70. PubMed ID: 2147211
[TBL] [Abstract][Full Text] [Related]
64. Comparative study of renal scintigraphy with 99Tcm-mercaptoacetyltriglycine and 123I-orthoiodohippurate.
Itoh K; Tsukamoto E; Kakizaki H; Nonomura K; Furudate M
Nucl Med Commun; 1993 Aug; 14(8):644-52. PubMed ID: 8371889
[TBL] [Abstract][Full Text] [Related]
65. The accuracy of quantitative parameters in (99m) Tc-MAG3 dynamic renography: a national audit based on virtual image data.
Brolin G; Edenbrandt L; Granerus G; Olsson A; Afzelius D; Gustafsson A; Jonsson C; Hagerman J; Johansson L; Riklund K; Ljungberg M
Clin Physiol Funct Imaging; 2016 Mar; 36(2):146-54. PubMed ID: 25348641
[TBL] [Abstract][Full Text] [Related]
66. Comparison of technetium-99m-ll-EC isomers in rats and humans.
Taylor A; Hansen L; Eshima D; Malveaux E; Folks R; Shattuck L; Lipowska M; Marzilli LG
J Nucl Med; 1997 May; 38(5):821-6. PubMed ID: 9170454
[TBL] [Abstract][Full Text] [Related]
67. Prospective validation of a single sample technique to determine technetium-99m-MAG3 clearance.
Taylor A; Corrigan P; Eshima D; Folks R
J Nucl Med; 1992 Sep; 33(9):1620-2. PubMed ID: 1387682
[TBL] [Abstract][Full Text] [Related]
68. First evaluation of a 99mTc-tricarbonyl complex, 99mTc(CO)3(LAN), as a new renal radiopharmaceutical in humans.
Lipowska M; He H; Malveaux E; Xu X; Marzilli LG; Taylor A
J Nucl Med; 2006 Jun; 47(6):1032-40. PubMed ID: 16741314
[TBL] [Abstract][Full Text] [Related]
69. The utility of 99mTc-mercaptoacetyltriglycine in captopril renography.
Taylor A; Martin LG
Am J Hypertens; 1991 Dec; 4(12 Pt 2):731S-736S. PubMed ID: 1837994
[TBL] [Abstract][Full Text] [Related]
70. [The estimation of effective renal plasma flow (ERPF) based on two compartment analysis using 99mTc-mercaptoacetyltriglycine (99mTc-MAG3)].
Ha-Kawa SK; Suga Y; Satou H; Tanaka Y
Kaku Igaku; 1994 Feb; 31(2):175-81. PubMed ID: 8121073
[TBL] [Abstract][Full Text] [Related]
71. Determination of extrarenal plasma clearance and hepatic uptake of technetium-99m-mercaptoacetyltriglycine in cats.
Drost WT; McLoughlin MA; Mattoon JS; Lerche P; Samii VF; DiBartola SP; Chew DJ; Barthez PY
Am J Vet Res; 2003 Sep; 64(9):1076-80. PubMed ID: 13677382
[TBL] [Abstract][Full Text] [Related]
72. [Pharmacokinetics of 99mTc-MAG3 and 131I-OIH: comparative study based on 2 compartment model analysis].
Shuke N; Takashio T; Sato J; Ishikawa Y; Saito Y; Yamamoto W; Aburano T; Mizunaga M; Kaneko S; Yachiku S; Ogawa Y; Kikuchi K; Sasajima T; Kubo Y
Kaku Igaku; 1996 May; 33(5):513-20. PubMed ID: 8699619
[TBL] [Abstract][Full Text] [Related]
73. Influence of hydration status in normal subjects: fractional analysis of parameters of Tc-99m DTPA and Tc-99m MAG3 renography.
Jung HS; Chung YA; Kim EN; Kim SH; Lee SY; Sohn HS; Park YH; Chung SK
Ann Nucl Med; 2005 Feb; 19(1):1-7. PubMed ID: 15770966
[TBL] [Abstract][Full Text] [Related]
74. Comparison of single-injection multisample renal clearance methods with and without urine collection.
Russell CD; Dubovsky EV
J Nucl Med; 1995 Apr; 36(4):603-6. PubMed ID: 7699449
[TBL] [Abstract][Full Text] [Related]
75. Technetium-99m MAG-3 clearances after captopril in experimental renovascular hypertension.
Lee HB; Blaufox MD
J Nucl Med; 1989 May; 30(5):666-71. PubMed ID: 2523959
[TBL] [Abstract][Full Text] [Related]
76. Preliminary results comparing OIH, 99mTc-MAG3 and iothalamate in a rat model of renal ischemia.
Eshima D; Greene J; Taylor A
Contrib Nephrol; 1990; 79():24-7. PubMed ID: 2146085
[No Abstract] [Full Text] [Related]
77. Prediction of urinary excretion of technetium-99m-MAG3.
Russell CD; Dubovsky EV; Taylor AT
J Nucl Med; 1998 Jul; 39(7):1257-9. PubMed ID: 9669405
[TBL] [Abstract][Full Text] [Related]
78. Simplified methods for estimation of 99mTc-pentetate and 131I-orthoiodohippurate plasma clearance in dogs and cats.
Barthez PY; Chew DJ; DiBartola SP
J Vet Intern Med; 2001; 15(3):200-8. PubMed ID: 11380028
[TBL] [Abstract][Full Text] [Related]
79. 99mTc-MAG3, a new renal imaging agent: preliminary results in patients.
Taylor A; Eshima D; Alazraki N
Eur J Nucl Med; 1987; 12(10):510-4. PubMed ID: 2952506
[TBL] [Abstract][Full Text] [Related]
80. Effect of advanced age on p-aminohippurate-induced inhibition of renal tubular secretion in male Fischer 344 rats.
Galinsky RE; Eshima D; Hansen L; Greene J; Dillehay D; Taylor A
Mech Ageing Dev; 1990 Dec; 56(3):209-22. PubMed ID: 2150974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
